Specsyn Laboratories Private Limited
About Specsyn Laboratories Private Limited
Data last updated:
Specsyn Laboratories Private Limited is a private limited company based in Hubli, Karnataka, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 25 July 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24290KA2022PTC164257.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Rekha Vivek Nayak and Reshma Ganapati Shankarling.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 131/1A Anchatageri Village Karwar Road, Hubli, Karnataka, India – 580024.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.51 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹42.08 Lakh (net margin -112.2%) and EBITDA of -₹24.77 Lakh (EBITDA margin -66%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Specsyn Laboratories Private Limited's registered office is in Hubli, Karnataka.
- Registered AddressNo. 131/1A Anchatageri Village Karwar Road, Hubli, Karnataka, India – 580024
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Specsyn Laboratories is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Specsyn Laboratories Private Limited, buy the company report.
Financials of Specsyn Laboratories Private Limited
FY 2025 filings availableSpecsyn Laboratories Private Limited reported revenue of ₹37.51 Lakh (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year. EBITDA rose 37% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹24.77 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹42.08 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -66% | ||
| Net Profit Margin | -112.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Specsyn Laboratories Private Limited, buy the company report.
Board of directors of Specsyn Laboratories Private Limited
Specsyn Laboratories has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Balakrishna Bhat | Additional Director | 11 Aug 2025 | 1 Years 2 Months | Current |
| Rekha Vivek Nayak | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
| Reshma Ganapati Shankarling | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
| Kamaldeep Raghuveer Nayak Also directs: Navika Bizcap Ventures LLP | Director | 25 Jul 2022 | 4 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Specsyn Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Specsyn Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Specsyn Laboratories Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Specsyn Laboratories Private Limited has 7 board changes on record since 2022: 4 appointments and 3 cessations. The latest: Rajesh Balakrishna Bhat was appointed as Additional Director on 11 Aug 2025.
Frequently asked questions
Specsyn Laboratories is an active private limited company based in Hubli, Karnataka, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 25 July 2022 (4+ years old) and is registered under CIN U24290KA2022PTC164257.
Specsyn Laboratories has 4 current directors:
- Rajesh Balakrishna Bhat - Additional Director
- Rekha Vivek Nayak - Director
- Reshma Ganapati Shankarling - Director
- Kamaldeep Raghuveer Nayak - Director
The latest financial statements of Specsyn Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Specsyn Laboratories is U24290KA2022PTC164257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Specsyn Laboratories was incorporated on 25 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
Rajesh Balakrishna Bhat was appointed as Additional Director on 11 Aug 2025. Rajesh Bhat Roopa ceased to be Director on 05 Jul 2024. Kamaldeep Raghuveer Nayak was appointed as Director on 25 Jul 2022. Specsyn Laboratories has 7 board changes on record in total.
The registered office of Specsyn Laboratories is at No. 1311A Anchatageri Village Karwar Road, Hubli, Karnataka, India – 580024.
Specsyn Laboratories operates in the chemicals and materials industry, in the industrial chemicals segment.
The compliance status of Specsyn Laboratories is compliant as of 18 July 2026. The company is actively filing with the Registrar of Companies.
Specsyn Laboratories can be reached at its registered office: No. 1311A Anchatageri Village Karwar Road, Hubli, Karnataka, India – 580024.